Medivation, Inc.
62.630.09 (0.14%)

After hours: 62.630.00 (0.00%) as of 5:35 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close62.54
Bid62.20 x 300
Ask63.17 x 800
52wk Range26.41 - 63.35
Day's Range62.50 - 63.35
Avg Vol (3m)2,760,515
As of 4:00 PM EDT. Market closed.
  • Benzinga2 days ago

    The Market In 5 Minutes: The Dow's Win Streak Comes To An End

    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in five minutes. Apply for daily AM access by clicking here or email ...

  • Forbes3 days ago

    Six Major Biotech Acquisitions You Could See In 2016 (Part 1)

    Biotech stocks have lagged this year. Should investors sell these stocks and invest in better performing sectors? Or, is this the best time in a long time to be buying biotech stocks now that they are relatively undervalued to other sectors? Todd Hagopian is buying because he believes the biotech industry is ripe for acquisitions as large, cash-flow rich drug companies look for promising new products.